DUBLIN--(BUSINESS WIRE)--The "Multiple Sclerosis -Epidemiology Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The Multiple Sclerosis - Epidemiology Forecast to 2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Multiple Sclerosis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The disease epidemiology covered in the report is segmented by Gender [male/female], age group [19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and 80 years], sub-types [Relapsing Remitting MS, Primary Progressive MS and Progressive relapsing MS] and Expanded disability status scale (EDSS) [0.0-1.5, 2.0-3.5, 4.0-5.5, 6.0-7.5 and 8.0-9.5], thus presenting overall detailed analysis of the patient pool characteristics.
The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
Key Topics Covered:
1. Report Introduction
2. Multiple Sclerosis Epidemiology Overview at a Glance
3. Disease Background and Overview: Multiple Sclerosis (MS)
4. Epidemiology and Patient Population
5. Epidemiology of Multiple Sclerosis
6. United States
11. United Kingdom
13. Unmet Needs
For more information about this report visit https://www.researchandmarkets.com/research/958xs5/multiple?w=4